Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:229-230 (24 January), doi:10.1136/bmj.328.7433.229-c
| The first 150 words of the full text of this article appear below. |
EDITORWe sympathise with Lock's frustration about the delay in establishing a British panel for preventing and managing biomedical research misconduct.1 Having produced this college's consensus conference statement,2 we worked with sister colleges to develop a blueprint for such a panel.3 The subsequent development of the panel was charged by UK colleges and other relevant bodies to the Academy of Medical Sciences. This item has been monitored closely by our audit and research committee, and, like Lock, we are disappointed that the academy has not made more progress.
After the meeting of the Committee on Publication Ethics (COPE) in October, where Lock spoke, it was proposed that the colleges should work with the General Medical Council, Universities UK, NHS Research and Development, and the Academy of Medical Sciences to ensure the progression of the panel. The Federation of Royal Colleges of Physicians of the UK has since confirmed its
Gordon D O Lowe, assessor
gdl1j@clinmed.gla.ac.uk, Royal College of Physicians of Edinburgh, Edinburgh EH2 1JG
Gordon D Murray, member
Consensus Panel on Misconduct in Biomedical Research, Royal College of Physicians of Edinburgh, Edinburgh EH2 1JG
Niall D Finlayson, president
Royal College of Physicians of Edinburgh, Edinburgh EH2 1JG